OnTrackCF for Cystic Fibrosis

(OnTrackCF Trial)

Recruiting at 2 trial locations

Overseen By Emma M McWilliams, BA

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Boston Children's Hospital

Must be taking: CFTR modulators

Disqualifiers: Safety concerns, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

60 Participants Needed

What You Need to Know Before You Apply

What is the purpose of this trial?

This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).

Who Is on the Research Team?

Kristin Riekert, PhD

Principal Investigator

Johns Hopkins University

Gabriela Oates, PhD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

Adults with Cystic Fibrosis who are prescribed CFTR modulator therapy twice daily, over 18 years old, and fluent in English. Participants must have regular access to an iOS or Android device with internet. Those whose safety or data quality may be compromised cannot join.

Inclusion Criteria

I am prescribed a CFTR modulator therapy to take twice daily.

I have been diagnosed with cystic fibrosis.

Can speak and read English

Exclusion Criteria

Any situation, in the opinion of the Investigator, that would compromise the safety of the patient or the quality of the data

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants use the OnTrackCF app for 4-12 weeks to evaluate feasibility, acceptability, and user engagement

4-12 weeks

Follow-up

Participants are monitored for engagement and usability through study completion

1 year

What Are the Treatments Tested in This Trial?

Interventions

• OnTrackCF

Trial Overview The OnTrackCF study is evaluating the use of a new tool designed for adults with Cystic Fibrosis to help them manage their treatment routine. It's not a drug trial but checks how well patients engage with and accept this technology.

How Is the Trial Designed?

Group I: Participation Experimental Treatment 1 Intervention

Participants eligible to enroll will be provided with the OnTrackCF app (intervention), and will use the app for 4-12 weeks before completing feasibility measures and a qualitative interview.

Who Is Running the Clinical Trial?

Boston Children's Hospital

Lead Sponsor

Trials

801

Recruited

5,584,000+

Cystic Fibrosis Foundation

Collaborator

Trials

199

Recruited

37,800+

Johns Hopkins University

Collaborator

Trials

2,366

Recruited

15,160,000+

University of Alabama at Birmingham

Collaborator

Trials

1,677

Recruited

2,458,000+